Monograph
M01AE52 - Naproxen and Esomeprazole |
Propably not porphyrinogenic |
PNP |
Rationale
This combination product contains two substances: naproxen (ATC code: M01A E02) and esomeprazole (ATC code: A02B C05). Both of them are safety classified as Probably not porphyrinogenic* (PNP*). The classification of this combination is therefore safety classified as Probably not porphyrinogenic. For more details please refer to the monographs of the two substances.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
Vimovo · Vimovo 500 mg/20 mg tabletten met gereguleerde afgifte · Vimovo 500 mg/20 mg, tabletten met gereguleerde afgifteBelgium
Vimovo · Vimovo 500 mg - 20 mg compr. lib. modif.United Kingdom
Naproxen / Esomeprazole · Naproxen 500mg / Esomeprazole 20mg modified-release tablets · Vimovo · Vimovo 500mg/20mg modified-release tabletsDenmark
EmoxenduoNorway
VimovoPoland
EmoxenLuxembourg
VimovoFinland
Emoxenduo · Vamtexar · VimovoLatvia
Esmapren
© NAPOS 2024